Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer
Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer
复制标题
DOI:
10.1186/s12943-020-01251-0
复制
发表时间:
2020-08-26
期刊:
影响因子:
37.3
通讯作者:
Kodera, Yasuhiro
中科院分区:
文献类型:
--
作者:
Kanda, Mitsuro;Shimizu, Dai;Kodera, Yasuhiro
Background Controlling metastasis is essential for improving the prognosis of patients with gastric cancer (GC). Here, we aimed to identify a molecule required for GC metastasis and to investigate its potential utility as a target for the development of therapeutic antibodies (Abs). Methods Transcriptome and bioinformatics analyses of human GC cell lines identified the neuronal pentraxin receptor (NPTXR) as a candidate molecule.NPTXRfunction was probed by modulating its expression in GC cells and assessing the effects on intracellular signaling and malignant behaviors in vitro and in mouse xenograft models. We also generated anti-NPTXR Abs andNptxr(-/-)mice, and assessed the clinical significance ofNPTXRexpression in GC specimens. Results NPTXRmRNA expression in clinical specimens was associated with disease progression and was significantly higher in tissues from GC patients with distant metastasis compared with those without.NPTXRregulated expression of genes involved in metastatic behaviors as well as activation of the PI3K-AKT-mTOR, FAK-JNK, and YAP signaling pathways.NPTXRsilencing promoted caspase-mediated apoptosis and attenuated GC cell proliferation, cell cycle progression, migration, invasion, adhesion, stem cell-like properties, and resistance to 5-fluorouracil in vitro, and also inhibited the tumorigenicity of GC cells in vivo. Anti-NPTXRAbs inhibited GC peritoneal metastasis in mice.Nptxr(-/-)mice showed no abnormalities in reproduction, development, metabolism, or motor function. Conclusions NPTXRplays an essential role in controlling the malignant behavior of GC cells in vitro and in vivo.NPTXR-targeting Abs may thus have utility as novel diagnostic tools and/or treatment modalities for GC.